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ABSTRACT 
International Journal of Exercise Science 6(3) : 217-229, 2013. The purpose was to 
determine the accuracy of the GT3X+ and Actiheart monitors for estimating energy expenditure 
(EE) and steps. Additionally, to investigate agreement between waist- and wrist-mounted GT3X+ 
EE outputs. Nineteen participants (mean age=30) completed three treadmill walking trials at self-
selected slow, medium, and fast speeds while wearing two GT3X+ (waist and wrist) and an 
Actiheart. Activity monitor EE was compared to indirect calorimetry criterion EE using Pearson 
correlations and ANOVAs. A Bland-Altman plot was used to investigate agreement between 
GT3X+ waist- and wrist-determined EE. GT3X+ determined steps were compared to researcher-
counted steps using ANOVAs. EE estimates from all monitors correlated highly with the criterion 
(r ranged from .72 to .82). However, the GT3X+ (waist and wrist) underestimated EE during slow 
walking and overestimated EE during fast walking. There were no differences among GT3X+ 
(waist and wrist) estimates of EE and the criterion during the medium trial. Actiheart estimated 
EE was not significantly different from measured EE during all trials. The Bland-Altman plot 
indicated that at EE rates above 4 kcal·min-1, the GT3X+ worn on the wrist underestimated EE 
compared to when it was worn on the waist. There were no differences between GT3X+ waist-
determined steps and researcher-counted steps for all trials. GT3X+ EE correlates highly with 
measured EE, but has poor absolute agreement during slow and fast walking. GT3X+ step 
estimates are accurate across the continuum of walking speeds when waist (but not wrist) 
mounted. Wrist-mounted device outputs are not comparable to waist-mounted outputs. The 
Actiheart accurately estimates EE. 
 




The current obesity pandemic burdens 
health systems across the world. This 
burden is likely to increase as more 
countries adopt increasingly sedentary 
lifestyles and increasingly unhealthy diets 
(11). Obesity is the result of complex 
interactions among energy intake, energy 
expenditure (EE), genetic characteristics, 
and environmental determinants (2). A 
better understanding of the relationships 
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among these factors may contribute to the 
control of this preventable disease. In order 
to improve our understanding, accurate 
measures of each component are needed. 
Of the two behavioral contributors to 
obesity (energy intake and EE), energy 
intake can be estimated using techniques 
such as weighed food intake and detailed 
food diaries (13). Although somewhat 
impractical, and not error-free, these 
techniques provide relatively accurate and 
reliable estimates for the energy intake side 
of the energy balance equation. 
 
Energy expenditure is arguably more 
difficult to estimate using practical and 
affordable measures, and typically requires 
cumbersome or expensive techniques such 
as indirect calorimetry or doubly-labeled 
water to obtain accurate measurements 
(25). Affordable ambulatory monitors that 
provide precise estimates of physical 
activity-related EE may provide important 
information to help understand the energy 
balance relationship. However, there is a 
lack of evidence for the accuracy of such 
measures for estimating EE in a metric that 
is comparable to energy intake (i.e., so that 
imbalances between energy intake and 
expenditure may be quantified).  
 
The Actigraph GT3X+ (Actigraph Inc., 
Pensacola, FL) is a new tri-axial 
accelerometer that provides data on several 
physical activity-related outcomes. This 
activity monitor is relatively new and 
therefore few studies have investigated its 
validity. Rowlands and Stiles (2012) found 
that GT3X+ acceleration values correlated 
between r = 0.59 and r = 0.87 with various 
measures of ground reaction force, and so 
the device shows promise for use in studies 
related to bone health. They also found that 
raw acceleration outputs differed between 
waist- and wrist-worn devices during brisk 
walking, whereby waist-worn devices 
provided higher outputs than wrist-worn 
devices (19). In another study, Carr and 
Mahar (2012) investigated the accuracy of 
the GT3X+ for measuring time spent in 
sedentary and light intensity activity, and 
also investigated the accuracy of the 
device’s inclinometer function. They found 
that the GT3X+ correctly estimated more 
than 80% of time in sedentary activities and 
between 23.7% and 75.5% of time spent in 
light activities. The inclinometer function of 
the GT3X+ correctly identified anatomical 
position between 60.6% and 66.7% of the 
time during sedentary activities (7). Finally, 
two other studies have been conducted to 
investigate agreement between different 
generations of Actigraph. One of these 
studies was conducted among adults (16) 
and the other among children and 
adolescents (17). These two studies 
investigated the inter-instrument 
agreement among several generations of 
Actigraph (including the GT3X+). 
However, they did not report on the 
accuracy of the GT3X+ compared to a 
criterion measure. To the authors’ 
knowledge, no study has been conducted to 
compare GT3X+ EE estimates to a criterion 
measure in adults. 
 
The primary aim of this study therefore, 
was to investigate the accuracy of the 
GT3X+ monitor for estimating physical 
activity-related EE under controlled 
walking conditions by comparing EE 
outputs from this device to a criterion 
measure (indirect calorimetry) and another 
validated physical activity and EE monitor 
(Actiheart, CamNtech Ltd., Cambridge, 
UK). The secondary aim was to determine 
the accuracy of the GT3X+ for estimating 
steps during walking. The final aim was to 
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investigate agreement between the GT3X+ 
for estimating EE when worn on two 
different body positions (i.e., waist and 
wrist). The National Health and Nutrition 
Examination Survey (NHANES) has 
recently changed its physical activity 
monitoring protocol. Participants now wear 
the accelerometer (GT3X+) on their wrist, 
rather than their waist, as they did in 
previous waves of data collection (8). The 
present study aims to determine whether 
this change in protocol will provide 
accurate estimates of physical activity EE.  
 
It should be noted that the monitors in this 
study do not measure EE or steps per se, 
rather they measure raw acceleration which 
is then interpreted by inbuilt mathematical 
algorithms in order to estimate the outcome 
of interest. In this regard, it is more accurate 
to state that we are evaluating the data 
processing models rather than the devices 
themselves. Although the processes 
involved between measurement and 
estimation may be straightforward in some 
instances (e.g., steps), it is more complex 
when other variables are estimated (e.g., 
total energy expenditure). The final result 
obtained from these devices is therefore 
heavily dependent on the mathematical 
algorithms applied, and not entirely on the 
raw data generated by the device. 
 
We selected walking as the physical activity 
of interest in this study because it is one of 
the most basic and widespread activities, 
and is an accessible entry-level activity for 
individuals with obesity. Furthermore, 
walking is rhythmic and repetitive, 
providing what should be distinctive 
movement patterns for the activity 
monitors to detect. If the devices 
demonstrate accuracy for estimating EE 
during walking, this would warrant further 
investigation of the devices during more 
complex free-living activities, such as 






Participants were 19 adults (13 males, 6 
females) with a mean age of 30 years (range 
= 19-53 years). Prior to testing, each 
participant provided written informed 
consent, and completed a physical activity 
readiness questionnaire (PAR-Q) (23) to 
identify any contraindications to 
participation. Approval to conduct the 
study was granted by the Ethical Review 
Board at the College of Life Science and 
Medicine at the University of Aberdeen, 
Scotland. All procedures conformed to the 
standards of the Helsinki Declaration. 
 
Measures 
Actigraph GT3X+ accelerometer: The 
ActiGraph GT3X+ (ActiGraph Inc., 
Pensacola, FL.) is a small (4.6 cm x 3.3 cm x 
1.5 cm) lightweight (19 g) tri-axial activity 
monitor that provides data on physical 
activity including activity counts, EE (kcal), 
steps, and activity intensity (METs). The 
device is waist- or wrist-worn on an elastic 
belt and activity is measured across three 
perpendicular planes. The GT3X+ has an 
inclinometer to determine body position 
(e.g., sitting, lying, and standing) and to 
identify periods of non-wear. Data (time 
varying accelerations in g’s) are recorded in 
a raw format at a user-specified sampling 
rate between 30 Hz and 100 Hz, in 10 Hz 
increments, and the device has an 
integrated ambient light sensor that 
provides information on the wearer’s 
environment. Data filtering and epoch 
selection are performed after data are 
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collected, allowing datasets to be processed 
multiple times at different epoch selections 
and using different cut-points after the data 
have been collected. The device is water 
resistant up to 1 m for 30 min and data can 
be collected for up to 40 days, using the 
available memory of 512 MB. The GT3X+ 
costs $250, and is therefore considerably 
less expensive than other measures of EE 
such as calorimetry and doubly labeled 
water. Prior to data collection, devices must 
be initialized. This involves selecting a start 
time, participant ID, sampling rate, device 
position on the body, and entering 
demographic and anthropometric data 
including date of birth, gender, race, height, 
and weight. Data are downloaded via a 
USB cable and subsequent data processing 
is conducted using the proprietary Actilife 
software (e.g., epoch selection, wear-time 
validation, and EE estimation). 
 
Actiheart accelerometer and heart rate 
monitor: The Actiheart (CamNtech Ltd., 
Cambridge, UK) is a combined 
accelerometer and heart-rate monitor that 
attaches to the chest via 
electrocardiography (ECG) pads. The 
device is comprised of three components: 1) 
a central circular unit (33 mm diameter) 
containing a piezo-electric accelerometer 
element, a battery, a non-volatile memory 
chip, and a clip that attaches to an ECG 
pad; 2) another small clip that attaches to a 
second ECG pad; and 3) a short (≈100 mm) 
wire connecting these two components. The 
accelerometer measures movement in the 
vertical plane and ECG signals are picked 
up via two ECG pads. One ECG pad is 
positioned at either V1 or V2. The other is 
positioned at either V4 or V5. The two ECG 
pads must be placed along the same 
horizontal plane for the accelerometer to 
function accurately. It has been shown that 
there are no differences in device output 
based on Actiheart position (i.e., upper 
chest vs. lower chest) (4). The device is 
initialized and data are downloaded by 
attaching the Actiheart to a docking station, 
which is in turn connected to a computer 
using a USB connection. 
 
Prior to collecting data a signal test must be 
carried out. This requires the wearer to 
attach the ECG pads and wear the Actiheart 
for approximately 10 min to ensure that a 
strong heart beat signal with little noise is 
being detected by the monitor. Following a 
successful signal test, the device can then be 
initialized to begin collecting data. If the 
signal test is unsuccessful then a stronger 
signal may be achieved by moving the 
location of the ECG pads and repeating the 
signal test. 
 
Several studies have investigated the 
validity and reliability of the Actiheart for 
measuring physical activity EE. Findings 
from these studies suggest that the 
Actiheart is an accurate measure of physical 
activity EE under controlled laboratory 
conditions among healthy adults (5), 
pregnant women (15), and children with 
chronic disease (22). It should be noted that 
several other studies have investigated the 
accuracy of another device called the 
Actiheart (3, 10, 21). The device referred to 
in these studies, however, is manufactured 
by a different company (Mini-Mitter 
Company Inc., USA) and uses different 
algorithms to estimate activity EE than the 
Actiheart in the present study.  
 
Although there is strong validity evidence 
available for this device, the Actiheart is 
considerably more expensive than the 
GT3X+ (approximately $1500), and may 
therefore be less accessible to researchers 
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with budgetary constraints. Additionally, 
the Actiheart is somewhat intrusive for the 
wearer and more labor-intensive for the 
researcher than the GT3X+. For example, 
participants need to remove clothing to 
attach ECG pads, and a successful signal 
test must be performed before data can be 
collected. One of the aims of this study 
therefore, was to determine if the GT3X+ 
may be used as a less expensive alternative 
to the Actiheart. 
 
Indirect calorimetry: The criterion measure 
of EE was achieved using indirect 




CO2 were measured using the Ultima CPX 
(Medical Graphics, St. Paul, MN) in 
combination with BreezeSuite software 
(version 6.4.1; Medical Graphics, St.Paul, 
MN). The Ultima CPX is a non-portable 
apparatus that requires participants to 
insert a mouthpiece connected to an 
umbilical cord which in turn connects to a 
unit containing O2 and CO2 sensors. 
Participants wear a nose clip to ensure that 
all expired air is monitored. 
 
Prior to data collection, the Ultima CPX was 
calibrated. This involved volume 
calibration via a large syringe which 
administered a known (3 liter) volume of 
air, and gas calibration using known 
concentrations of O2 (21%) and CO2 (5%). 
 
Protocol 
Participants provided information on their 
age and gender. Height was measured 
using a stadiometer (Holtain Ltd., 
Crosswell, UK) and weight was measured 
using weighing scales (Seca, Hamburg, 
Germany). Participants’ resting heart rate 
was measured (beats per minute), and their 
predicted maximum heart rate (220 – age) 
and predicted sleeping heart rate (resting 
heart rate – 10) were also recorded. These 
values were subsequently used during the 
Actiheart initialization process. Barometric 
pressure was recorded prior to each testing 
session and entered into the gas analyzer 
for indirect calorimetry calculations. All 
testing was conducted in an environmental 
chamber with a consistent temperature of 
18.0 °C and 50% humidity. Prior to testing, 
two GT3X+ devices were initialized and 
fitted to the participant (one on the right 
wrist and one on the right side of the 
waist), an Actiheart signal test was 
conducted, and the Ultima CPX was 
calibrated. The testing protocol was 
explained to participants and they were 
given the opportunity to familiarize 
themselves with walking on the treadmill 
and breathing while wearing the Ultima 
CPX mouthpiece and nose clip.  
 
The testing protocol consisted of three 
treadmill walking trials, each lasting 10 
min. Each of the trials was conducted at a 
different speed. For the first trial, 
participants were asked to walk at a speed 
that they thought was slow. Participants 
were asked to walk at a medium speed for 
the second trial. Finally, for the third trial 
participants were asked to walk at a speed 
that they thought was fast. The treadmill 
speed was controlled by the participant and 
not the researcher. Expired air was 
measured for the final 5 min of each trial 
(i.e., once participants had reached steady 
state), and steps were counted during the 
eighth min of each trial by a member of the 
research team. A digital watch was used to 
record the start and end times of each trial. 
The watch had been synchronized with the 
computer used to initialize the GT3X+s and 
Actiheart, allowing for exact time-stamps to 
be created. This was crucial for subsequent 
data processing. GT3X+s were selected 
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from a pool of 15 devices and were set to 
record data at a sampling rate of 30 Hz. 
Actihearts were selected from a pool of 8 
devices and sampled at 15 sec epochs, as 
this was the default sampling rate for the 
short-term advanced EE setting that was 
selected for data collection. 
 
Data Processing 
GT3X+: GT3X+ data were downloaded via 
a USB cable and uploaded into Actigraph’s 
proprietary data processing software 
(Actilife version 6). For data generated from 
devices worn on the wrist, the ‘Worn on 
wrist’ option was selected during the data 
scoring stage. EE (kcal) was calculated for 
the final 5 min of each walking trial using 
the prediction equation developed by 
Sasaki, John, and Freedson (2011)(20), 
labeled the ‘Freedson VM3 (2011)’ equation 
in the Actilife software. This equation uses 
the vector magnitude to predict kcals (i.e., a 
combination of the three accelerometer 
planes). Additionally, the low frequency 
extension (LFE) option was selected at the 
download stage. This option lowers the 
baseband of the filter cut-off, expanding the 
bandwidth of the accumulated data. This 
was selected to ensure movement at the 
slow walking speeds was detected. The 
total EE value for the final 5 min of walking 
for each trial was divided by five to obtain a 
value for kcal·min-1. Steps were also 
calculated during the same min as the 
researcher-counted steps. The GT3X+ failed 
to collect data for three participants, leaving 
a final sample of 16 participants. The reason 
for the device malfunction is unclear. 
 
Actiheart: Actiheart data were downloaded 
via a device docking station and processed 
using Actiheart software (CamNtech Ltd., 
Cambridge, UK). On attempting to 
download one participant’s data it became 
evident that the Actiheart had failed to 
record any data, resulting in complete 
Actiheart data for 18 of the 19 participants. 
EE for the final 5 min of each trial was 
calculated using a branched modeling 
equation (labeled as Group Cal JAP2007 in 
the software). This applied a flex heart rate 
algorithm for data below 25 accelerometer 
counts per min, and an alternate algorithm 
known as transition heart rate for data 
above 25 counts per min. This branched 
equation has been described in detail 
elsewhere (6). The branched model 
predicted EE in calories for the final five 
min of each walking trial. Total cal were 
divided by 1000 to achieve total kcal, and 







for the final 5 min of each walking trial 
were used to calculate kJ·min-1 using the 
Weir formula (24), which takes into account 
the energy derived from different fuel 
sources. The resulting value was multiplied 
by 0.238 to obtain kcal·min-1 (1). Body 
weight, height, and age were used to 
calculate resting metabolic rate (RMR) (12) 
for each participant. This RMR value was 
then subtracted from their total EE value 
for each walking trial, giving a final value 
for physical activity-related EE. Kcal·min-1 
as determined by indirect calorimetry was 
used as the criterion value against which to 




Descriptive statistics were calculated to 
characterize the sample and aspects of the 
treadmill walking trials. Pearson’s product 
moment correlation r was calculated 
between measured EE values and EE 
estimates from each activity monitor. Data 
were combined across trials for 
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correlational analyses. Repeated measures 
ANOVAs were used to investigate 
differences among measures for estimates 
of EE (kcal·min-1). Three ANOVAs were 
used (one for each walking trial). Fisher 
post-hoc pairwise comparisons were used 
to investigate differences between 
individual pairs of measures, adjusted 
using the Bonferroni method to control for 
multiple comparisons. Cohen’s d was used 
to determine effect sizes (9). The same 
ANOVA analyses were used to investigate 
differences between researcher-counted 
steps and GT3X+ estimated steps (waist 
and wrist) for each walking trial. An 
adapted Bland Altman plot (14) with 95% 
limits of agreement was used to assess 
agreement between GT3X+ waist and 
GT3X+ wrist estimates of EE, pooled across 
walking trials. IBM SPSS Statistics (Version 
20, IBM Corp., Armonk, NY.) was used for 




A total of 19 adults (mean age = 30 years, 
SD = 9) participated in the study. The 
average participant weight was 71.46 kg 
(SD = 10.55) and the average height was 
174.37 cm (SD = 9.16). The mean walking 
speeds for each trial were: Slow = 2.59 
km/hr (SD = 0.87), Medium = 3.74 km/hr 
(SD = 0.82), and Fast = 5.12 km/hr (SD = 
0.81). Descriptive statistics for each 
outcome during the three trials are 
displayed in Table 1. 
 
Significant positive correlations at the p < 
.01 level were found between indirect 
calorimetry estimates of EE and EE outputs 
from the GT3X+ waist (r = .82), the GT3X+ 
wrist (r = .72), and the Actiheart (r = .77). 
The omnibus ANOVA tests indicated 
significant differences among measures of 
EE for the slow (F (df = 3, 42) = 9.64, p < .01) 
and fast (F (df = 3, 42) = 26.42, p < .01) 
walking trials. There were no significant 
differences among measures of EE during 
the medium walking trial (F (df = 3, 42) = 
2.42, p > .05). Pairwise differences between 
each device and EE from indirect 
calorimetry during the slow and fast trials 
are displayed in Table 2. The GT3X+ worn 
on the waist and wrist significantly 
underestimated EE during the slow 
walking trial, and significantly 
overestimated EE during the fast walking 
trial. EE estimates from the Actiheart were 
not significantly different than calorimetry 
measured EE for any trial. 
 
The ANOVA results indicated that there 
were no significant differences among 
devices for step estimates during the slow 
walking trial (F (df = 1, 16) = 3.13, p > .05). 
Significant differences in step estimates 
were found among devices for the medium 
(F (df = 1, 20) = 8.96, p < .01) and fast (F (df 
= 1, 15) = 12.82, p < .01) walking trials. Post-
hoc comparisons showed that in the 
medium and fast walking trials the GT3X+ 
worn on the wrist significantly 
underestimated steps. These differences 
were medium to large according to Cohen’s 
d. Step estimates from the GT3X+ worn at 
the waist were not significantly different 
from researcher-counted steps for all trials. 
Details of the post-hoc comparisons for the 
medium and fast trials are displayed in 
Table 3. 
 
An adapted Bland-Altman plot (Figure 1) 
was created to investigate agreement 
between waist- and wrist-worn GT3X+ 
determined EE, pooled across walking 
trials. Scores from the GT3X+ worn on the 
waist were plotted on the x axis because 
this is the device position typically used by 
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Table 1. Descriptive statistics for each walking trial 1"
Trial Outcome n Mean SD Min. Max. Skew. Kurt. 
Slow         
 Speed (Km/h) 19 2.59 0.87 1.1 4 -0.07 -0.84 
 Counted steps 19 86 17 54 116 -0.13 -0.61 
 GT3x+ waist steps 16 74 20 40 107 -0.04 -1.09 
 GT3x+ wrist steps 16 80 16 52 107 -0.22 -.75 
 Measured kcal·min-1 19 2.05 0.78 0.87 4.03 1.07 1.28 
 GT3x+ waist kcal·min-1 16 1.17 1.21 0.00 3.64 0.89 -0.40 
 GT3x+ wrist kcal·min-1 16 0.74 0.83 0.00 2.8 1.84 2.33 
 Actiheart kcal·min-1 18 1.72 1.15 0.40 5.02 1.54 2.89 
Medium         
 Speed (Km/h) 19 3.74 0.82 2 5.50 -0.13 0.36 
 Counted steps 19 102 12 81 124 0.02 -0.52 
 GT3x+ waist steps 16 97 10 80 116 -0.08 -0.26 
 GT3x+ wrist steps 16 92 12 71 109 -0.12 -0.94 
 Measured kcal·min-1 19 2.53 0.82 1.19 4.38 0.83 0.43 
 GT3x+ waist kcal·min-1 16 3.04 1.77 0.2 6.12 -0.06 -0.53 
 GT3x+ wrist kcal·min-1 16 2.59 1.62 0.12 5.02 0.15 -1.54 
 Actiheart kcal·min-1 18 2.48 1.41 0.99 6.89 2.01 4.87 
Fast         
 Speed (Km/h) 19 5.12 0.81 3.5 6.5 -0.51 -0.15 
 Counted steps 19 116 10 98 136 0.28 -0.47 
 GT3x+ waist steps 16 113 8 98 127 0.22 -0.34 
 GT3x+ wrist steps 16 99 15 61 120 -1.08 1.55 
 Measured kcal·min-1 19 3.55 1.18 1.54 6.01 0.79 0.39 
 GT3x+ waist kcal·min-1 16 5.16 1.57 1.38 7.90 -0.74 1.50 
 GT3x+ wrist kcal·min-1 16 4.14 1.19 2.32 6.22 -0.07 -1.21 
 Actiheart kcal·min-1 18 3.41 1.74 1.22 8.94 2.04 5.59 
 2"
GT3X+ AND ACTIHEART VALIDITY 
International Journal of Exercise Science                                                          http://www.intjexersci.com 
225 
 
Figure 1. Adapted Bland Altman plot displaying 
agreement between GT3X+ waist and wrist EE 
estimates pooled across walking trials. 
 
most researchers, not because we deemed it 
to be the criterion. Differences between 
measures (i.e., waist – wrist) were plotted 
on the y axis and 95% limits of agreement 
(mean difference ± 2 SD) were also added 
to the plot. 
 
The Bland Altman plot indicates 
proportional bias, increasing at higher rates 
of EE. At EE rates above 4 kcal·min-1, the 
GT3X+ worn on the wrist appears to 
underestimate compared to when it is worn 
on the waist. This indicates a lack of 




This study is the first to examine the 
accuracy of the Actigraph GT3X+ 
accelerometer for estimating EE in adults 
during walking, and to provide a 
comparison with the Actiheart activity 
monitor. EE is an important variable in the 
etiology of obesity, and therefore affordable 
accurate measurement instruments may 
Table 2. Differences between measured kcal·min-1 and kcal·min-1 estimates from each device. 1"
Trial Device n Mean diff. p d 95% CI 
Slow       
 GT3X+ Waist 15 0.77    .04 0.76 0.04 – 1.51 
 GT3X+ Wrist 15 1.22 < .01 1.58 0.45 – 1.99 
 Actiheart 15 0.42     .36 0.51 -0.21 – 1.04 
Fast       
 GT3X+ Waist 15 -1.90 < .01 -1.59 -2.77 - -1.04 
 GT3X+ Wrist 15 -0.96  .02 -0.95 -1.77 - -0.14 
 Actiheart 15 0.12 1.00 0.13 -0.45 – 0.70 
Notes. d = Cohen’s d, 95% CI = 95% confidence interval for difference 2"
Table 3. Difference between researcher-counted steps/min and steps/min from each device. 1"
Trial Device n Mean diff. p d 95% CI 
Medium       
 GT3X+ Waist 16 2 .32 0.20 -1.10 – 4.92 
 GT3X+ Wrist 16 7 .02 0.63 1.18 – 13.07 
Fast       
 GT3X+ Waist 16 1 .25 0.13 -0.29 – 1.56 
 GT3X+ Wrist 16 14 < .01 1.25 3.80 – 24.40 
Notes. d = Cohen’s d, 95% CI = 95% confidence interval for difference 2"
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permit a better understanding of the energy 
intake-expenditure relationship. 
Additionally, given that Actigraph Inc. is 
one of the primary producers of research-
grade accelerometers, it is necessary to 
ensure that each new model provides 
trustworthy data for researchers interested 
in physical activity outcomes. 
 
We found that EE estimates from the 
GT3X+ worn on the waist and wrist, and 
the Actiheart monitor correlate highly with 
EE measured by indirect calorimetry. These 
findings indicate good relative validity for 
the activity monitors (i.e. the monitors place 
participants in a similar order of EE as 
indirect calorimetry). Additionally, the 
GT3X+ worn on the wrist and waist 
provides accurate estimates of EE at 
medium walking speeds (i.e., 2 – 5.50 
km/h), and can accurately determine steps 
at all walking speeds when worn on the 
waist. However, the GT3X+ 
underestimated EE during slow walking 
and overestimated EE during fast walking, 
when worn on both body positions. This 
suggests that there is not absolute 
agreement between GT3X+ EE estimates 
and measured EE across the continuum of 
walking speeds. The Freedson VM3 2011 
equation used to calculate EE in the Actilife 
software was developed using a protocol 
that included walking and running (20). It 
has been shown that across a wide range of 
walking and running cadences, the 
cadence-EE relationship appears to be non-
linear (18). Specifically, the cadence-EE 
relationship for walking constitutes a 
shallow linear relationship, whereas the 
relationship is steeper during running 
cadences. It is possible therefore, that the 
combination of walking and running used 
to develop the VM3 2011 equation applied 
to the data in the present study may partly, 
or entirely, account for the absolute 
differences in GT3X+ estimated EE and 
measured EE that we observed. Perhaps a 
more accurate approach would be to create 
EE algorithms that discriminate between 
walking and running, or account for the 
curvilinear nature of the cadence-EE 
relationship (for example by log-
transforming the EE data). It should be 
noted that the discrete walking trials (i.e., 
slow, medium, and fast) that we used 
somewhat artificially grouped walking 
speeds together that are, in fact, part of a 
continuum. As such, there was a large 
overlap between the speeds from each trial, 
as can be seen in Table 1. The high linear 
relationship between GT3X+ estimated EE 
and calorimetry (comparable to the 
relationship for the Actiheart) indicates that 
with a relatively straightforward 
adjustment of the GT3X+ data-processing 
algorithms, accuracy might be achieved 
across the speed continuum. 
 
We used the LFE option when 
downloading the GT3X+ data. This feature 
lowers the accelerometer baseband to 
include movements typically classified as 
being outside the normal range of human 
movement. Using this function should help 
to detect activity and steps at slower 
walking speeds or among individuals with 
non-normal walking gaits, such as the 
elderly. However, even with the LFE 
applied, the devices in our study 
underestimated physical activity EE at slow 
walking speeds. Steps were, however, 
accurately detected at the slow walking 
speeds when the device was worn on the 
waist. Researchers seeking to obtain 
conservative estimates of physical activity 
EE or who are interested in higher intensity 
activity may choose not to use the LFE, 
whereas those concerned about screening-
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out bona fide activity or who are interested 
in light intensity activity may wish to apply 
it. A study by Ried-Larsen et al (2012) is 
somewhat helpful in this regard. They 
found that GT3X+ output (activity counts) 
was higher when the LFE option was 
enabled compared to when it was disabled 
(16). Data were collected under both 
controlled mechanical and free-living 
conditions. However, in that study they 
only used this information to compare 
accuracy among different generations of 
Actigraph accelerometers, and did not 
establish which output (LFE enabled vs. 
disabled) was most similar to a known 
criterion. 
 
An important finding from the present 
study is that when worn on the wrist, the 
GT3X+ is less accurate at determining steps 
than when worn on the waist. We found 
that the GT3X+ worn on the wrist did not 
accurately determine steps at medium and 
fast walking speeds, whereas steps were 
accurately estimated at all walking speeds 
when worn on the waist. Furthermore, poor 
agreement for EE estimates between waist- 
and wrist-mounted GT3X+ devices was 
exhibited by the adapted Bland Altman 
plot. The plot indicated that as the rate of 
EE increased, so did the rate of bias, such 
that the GT3X+ worn on the wrist 
systematically underestimated EE above a 
rate of 4 kcals·min-1. The reason for this 
underestimation when the GT3X+ is worn 
on the wrist may be related to the algorithm 
used to calculate EE. The Freedson VM3 
2011 equation used in the Actilife software 
to calculate EE was developed using data 
from waist-worn devices (20). In order to 
calculate EE when the device is worn at the 
wrist, the Actilife software applies scaling 
to the accelerometer counts. These scaling 
values have yet to be validated, and may 
therefore contribute somewhat to the 
differences in output from waist- and wrist-
worn devices. This is a particularly 
important finding given that the National 
Health and Nutrition Examination Survey 
(NHANES) will soon move to a wrist-
mounted accelerometer protocol after 
several years of using a waist-mounted 
protocol (8). However, based on the 
findings of our study, this change in 
protocol will lead to a situation where 
previously collected data will not be 
comparable to future data, and may also 
lead researchers to conclude that activity 
levels are lower than they really are. 
Interestingly, our findings are consistent 
with those of Rowlands and Stiles (2012), 
who found that GT3X+ raw acceleration 
outputs during brisk walking were higher 
for waist-mounted GT3X+ devices than for 
those worn on the wrist. Similarly, they 
found no differences in output between 
device locations for slow walking. These 
findings were based on raw accelerometer 
values, and may therefore indicate that 
genuine differences in output exist between 
device locations, and differences may not 
be due to the scaling values that are applied 
at the data processing stage, as argued 
above. 
 
Similar to previously conducted studies, we 
found that the Actiheart monitor provided 
accurate estimates of EE. This is 
unsurprising given that the Actiheart, in 
contrast to the GT3X+, uses combined 
accelerometer and heart rate data to 
provide EE estimates. Error associated with 
the movement-EE relationship is reduced 
by the inclusion of this heart rate data. 
Previous studies that have investigated 
Actiheart validity have found that it is a 
valid measure of movement, EE, and heart 
rate in several populations (5, 15, 22). In this 
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regard, our study provides support for the 
continued use of the Actiheart in studies 
where EE is the primary outcome. 
 
This study used a relatively small sample 
and did not include any free-living physical 
activities. Future studies should address 
these limitations. Additionally, future 
research should seek to develop EE 
prediction equations that account for the 
different relationships between walking 
and running cadences/speeds and EE. This 
may help to improve the accuracy of 
accelerometer-based activity monitors. 
 
Accelerometers afford a more practical and 
cost-effective means of measuring EE 
compared to techniques such as indirect 
calorimetry or doubly labeled water. The 
Actigraph GT3X+ accelerometer correlates 
highly with measured EE when worn on 
the wrist and waist, and provides accurate 
estimates of steps during slow, medium, 
and fast walking when worn on the waist. 
However, the GT3X+ significantly 
underestimated EE during slow walking 
and overestimated EE during fast walking.  
Absolute differences observed between 
measured EE and GT3X+ estimated EE may 
be the result of systematic sources of bias 
that could be accounted for by adapting the 
algorithms that convert the acceleration 
signal to kcal. Researchers should be 
cautious about positioning devices on 
participants’ wrists, as the resultant data 
are not comparable to that collected from 
waist-worn devices. The Actiheart 
provided accurate estimates of EE at slow, 




Funding to purchase the equipment used in 
this study was provided via an equipment 
grant from the Rowett Institute of Nutrition 
and Health, University of Aberdeen. This 
manuscript underwent internal peer review 
at the Rowett Institute of Nutrition and 
Health, University of Aberdeen before 




1. A report of the panel on macronutrients 
subcommittees on upper reference levels of 
nutrients and interpretation and uses of dietary 
reference intakes. Standing committee on the 
scientific evaluation of dietary reference intakes. 
Dietary Reference Intakes for Energy, Carbohydrate, 
Fiber, Fat, Fatty Acids, Cholesterol, Protein, and 
Amino Acids (Macronutrients). The National 
Academies Press 2005: 1-1357.  
2. Aronne L, Nelinson D, Lillo J. Obesity as a disease 
state: A new paradigm for diagnosis and treatment. 
Clin Cornerstone 9(4): 9-29, 2009.  
3. Barreira TV, Kang M, Caputo JL, Farley RS, 
Renfrew MS. Validation of the Actiheart monitor for 
the measurement of physical activity. Int J Exerc Sci 
2: 60-71, 2009.  
4. Brage S, Brage N, Ekelund U, Luan J, Franks PW, 
Froberg K, Wareham NJ. Effect of combined 
movement and heart rate monitor placement on 
physical activity estimates during treadmill 
locomotion and free-living. Eur J Appl Physiol 96(5): 
517-524, 2006.  
5. Brage S, Brage N, Franks PW, Ekelund U, 
Wareham NJ. Reliability and validity of the 
combined heart rate and movement sensor 
Actiheart. Eur J Clin Nutr 59(4): 561-570, 2005.  
6. Brage S, Brage N, Franks PW, Ekelund U, Wong 
MY, Andersen LB, Froberg K, Wareham NJ. 
Branched equation modeling of simultaneous 
accelerometry and heart rate monitoring improves 
estimate of directly measured physical activity 
energy expenditure. J Appl Physiol 96(1): 343-351, 
2004.  
GT3X+ AND ACTIHEART VALIDITY 
International Journal of Exercise Science                                                          http://www.intjexersci.com 
229 
7. Carr LJ, Mahar MT. Accuracy of intensity and 
inclinometer output of three activity monitors for 
identification of sedentary behavior and light-
intensity activity. J Obes [Internet]. 2012 [Cited 2012 
October 15]. Available from:  
http://www.hindawi.com/journals/jobes/2012/46
0271/. doi:10.1155/2012/460271 
8. Centers for Disease Control. National Health and 
Nutrition Examination Survey (NHANES): Physical 
Activity Monitor (PAM) Procedures Manual 1-36, 
2011.  
9. Cohen J. Statistical Power Analysis for the 
Behavior Sciences. 2nd ed. Hillsdale, NJ: Lawrence 
Erlbaum Associates, Inc.: 1-596, 1988. 
10. Crouter SE, Churilla JR, Bassett DR,Jr. Accuracy 
of the Actiheart for the assessment of energy 
expenditure in adults. Eur J Clin Nutr 62(6): 704-711, 
2008.  
11. Finkelstein EA, Khavjou OA, Thompson H, 
Trogdon JG, Pan L, Sherry B, Dietz W. Obesity and 
severe obesity forecasts through 2030. Am J Prev 
Med 42(6): 563-570, 2012.  
12. Harris JA, Benedict FG. A biometric study of 
human basal metabolism. Proc Natl Acad Sci U S A 
4(12): 370-373, 1918.  
13. Johnson RK. Dietary intake: How do we measure 
what people are really eating? Obes Res 10 Suppl 1: 
63S-68S, 2002.  
14. Bland MJ, Altman D. Statistical methods for 
assessing agreement between two methods of 
clinical measurement. The Lancet 327(8476): 307-310, 
1986.  
15. Melzer K, Lazzeri M, Armand S, Boulvain M, 
Schutz Y, Kayser B. Validation of the Actiheart for 
estimating physical activity related energy 
expenditure in pregnancy. e-SPEN Journal 7(1):e5-
e10, 2012.  
16. Ried-Larsen M, Brond JC, Brage S, Hansen BH, 
Grydeland M, Andersen LB, Moller NC. Mechanical 
and free living comparisons of four generations of 
the Actigraph activity monitor. Int J Behav Nutr 
Phys Act 9(1): 113, 2012.  
17. Robusto KM, Trost SG. Comparison of three 
generations of ActiGraph activity monitors in 
children and adolescents. J Sports Sci 30(13): 1429-
1435, 2012.  
18. Rowe DA, Tudor-Locke C. Walking the (curved) 
line: Investigation of the cadence-energy 
expenditure relationship during ambulatory 
activity. In: AAHPERD Measurement and 
Evaluation Symposium: Boston, MA, 2012.  
19. Rowlands AV, Stiles VH. Accelerometer counts 
and raw acceleration output in relation to 
mechanical loading. J Biomech 45(3): 448-454, 2012.  
20. Sasaki JE, John D, Freedson PS. Validation and 
comparison of ActiGraph activity monitors. J Sci 
Med Sport 14(5): 411-416, 2011.  
21. Spierer DK, Hagins M, Rundle A, Pappas E. A 
comparison of energy expenditure estimates from 
the Actiheart and Actical physical activity monitors 
during low intensity activities, walking, and jogging. 
Eur J Appl Physiol 111(4): 659-667, 2011.  
22. Takken T, Stephens S, Balemans A, Tremblay 
MS, Esliger DW, Schneiderman J, Biggar D, 
Longmuir P, Wright V, McCrindle B, Hendricks M, 
Abad A, van der Net J, Beyene J, Feldman BM. 
Validation of the Actiheart activity monitor for 
measurement of activity energy expenditure in 
children and adolescents with chronic disease. Eur J 
Clin Nutr 64(12): 1494-1500, 2010.  
23. Thomas S, Reading J, Shephard RJ. Revision of 
the physical activity readiness questionnaire (PAR-
Q). Can J Sports Sci 17(4): 338-345, 1992.  
24. Weir JB. New methods for calculating metabolic 
rate with special reference to protein metabolism. J 
Physiol 109(1-2): 1-9, 1949.  
25. Westerterp KR. Assessment of physical activity: 
A critical appraisal. Eur J Appl Physiol 105(6): 823-
828, 2009. 
 
 
